Used primarily in neuroscience research to induce Parkinson-like symptoms in animal models. It is metabolized in the body to MPTP, a potent neurotoxin that selectively damages dopaminergic neurons in the substantia nigra, mimicking the pathological features of Parkinson’s disease. This makes it a valuable tool for studying disease mechanisms and testing potential therapeutic agents. Due to its specificity, it helps researchers evaluate neuroprotective strategies and assess the efficacy of new drugs targeting dopamine pathways. Strictly handled under controlled laboratory conditions due to high toxicity.